1,351
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Agreement between self-reported and central cancer registry-recorded prevalence of cancer in the Alaska EARTH study

, ORCID Icon, , & ORCID Icon
Article: 1571383 | Received 09 Aug 2018, Accepted 10 Jan 2019, Published online: 06 Feb 2019
 

ABSTRACT

Reliance on self-reported health status information as a measure of population health can be challenging due to errors associated with participant recall. We sought to determine agreement between self-reported and registry-recorded site-specific cancer diagnoses in a cohort of Alaska Native people. We linked cancer history information from the Alaska Education and Research Towards Health (EARTH) cohort and the Alaska Native Tumor Registry (ANTR), and calculated validity measures (sensitivity, specificity, positive predictive value, negative predictive value, kappa). Multiple logistic regression models were used to assess independent associations of demographic variables with incorrect reporting. We found that among Alaska EARTH participants, 140 self-reported a history of cancer, and 99 matched the ANTR. Sensitivity ranged from 79% (colorectal cancer) to 100% (prostate cancer); specificity was over 98% for all-sites examined. Kappa was higher among prostate and female breast cancers (κ=0.86) than colorectal cancers (κ=0.63). Women (odds ratio [OR] (95% confidence interval [CI]): 2.8 (1.49–5.31)) and participants who were older than 50 years (OR (95% CI): 2.8 (1.53–4.12)) were more likely to report incorrectly. These data showed good agreement between self-reported and registry-recorded cancer history. This may be attributed to the high quality of care within the Alaska Tribal Health System, which strongly values patient-provider relationships and the provision of culturally appropriate care.

Conflict of Interest

No potential conflict of interest was reported by the authors.

Supplementary material

Supplementary material for this article can be accessed here.

Additional information

Funding

Dr Nash, Mr Zimpelman and the Alaska Native Tumor Registry are supported by the National Cancer Institute (NCI), Surveillance, Epidemiology and End Results Program, NCI contract number HHSN26120130010I, Task Order HHSN26100005. The Alaska EARTH study was funded by NCI grants CA88958 and CA96095.